levodopa has been researched along with Abnormalities, Autosome in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Chan, CC; Chao, CC; Chen, ML; Cheng, J; Daida, K; Farrer, M; Funayama, M; Hattori, N; Hsieh, ST; Huang, CY; Hung, YC; Jeon, B; Ke, YC; Lai, HJ; Lee, NC; Li, Y; Lin, CH; Lin, HY; Lo, WC; Mukai, Y; Nishioka, K; Sato, K; Takahashi, Y; Tsai, HH; Tsai, PI; Tzeng, SR; Wu, RM; Wu, YS; Yen, RF; Yoshino, H | 1 |
| Furuya, H; Ichinose, H; Kira, J; Kishi, T; Murai, H; Ohyagi, Y; Takasugi, K; Urano, F | 1 |
| Brockmann, K; Feiner, C; Henke, L; Müller, U; Steinberger, D; Troidl, C; von der Hagen, M; Zirn, B | 1 |
| Bezard, E; Brotchie, JM; Fox, SH; Hallett, PJ; Lubin, FD; Nicholas, AP; Ravenscroft, P; Standaert, DG; Sweatt, JD; Vattem, P; Zhou, S | 1 |
| Gök, F; Gökçay, E; Gül, D; Sayli, BS | 1 |
| Ishikawa, A; Miyatake, T | 1 |
| Nygaard, TG | 1 |
| Furukawa, Y; Mizuno, Y; Narabayashi, H; Nishi, K | 1 |
| Dasouki, M; Hiari, M; Mubaidin, A; Najim al-Din, AS; Wriekat, A | 1 |
| Chutorian, A | 1 |
| Heberlein, I; Müller, U; Nitschke, M; Otto, V; Steinberger, D; Vieregge, P | 1 |
| Perlmutter, JS; Racette, BA | 1 |
| Bergamaschi, R; Cacciari, E; Cicognani, A; Gualandi, S; Mazzanti, L; Nanni, S; Perri, A; Pirazzoli, P; Scarano, E; Zucchini, S | 1 |
| Calne, DB; Dobko, T; Mak, E; Markopoulou, K; Samii, A; Sossi, V; Stoessl, AJ; Wszolek, ZK | 1 |
| Ko, CH; Kong, CK; Lam, CW; Tong, SF | 1 |
| Evidente, VG; Gwinn-Hardy, K; Hardy, J; Hernandez, D; Singleton, A | 1 |
2 review(s) available for levodopa and Abnormalities, Autosome
| Article | Year |
|---|---|
Dopa-responsive dystonia.
Topics: Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Corpus Striatum; Diagnosis, Differential; DNA Mutational Analysis; Dystonia; Genes, Dominant; GTP Cyclohydrolase; Humans; Infant; Levodopa; Neural Pathways; Parkinson Disease, Secondary; Phenotype; Spinal Cord; Substantia Nigra | 1995 |
[Parkinsonian syndromes in children].
Topics: Adolescent; Adult; Child; Chromosome Aberrations; Chromosome Disorders; Humans; Levodopa; Parkinson Disease | 1997 |
14 other study(ies) available for levodopa and Abnormalities, Autosome
| Article | Year |
|---|---|
Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy.
Topics: Age of Onset; Aged; Animals; Antiparkinson Agents; Cell Line; Chromosome Aberrations; Drosophila; Electron Transport Complex III; Exome Sequencing; Female; Frameshift Mutation; Gene Knock-In Techniques; Genes, Dominant; Humans; Levodopa; Male; Mice; Middle Aged; Mitochondria; Mutation; Parkinsonian Disorders; Pedigree; Polyneuropathies | 2020 |
A case of late-onset Segawa syndrome (autosomal dominant dopa-responsive dystonia) with a novel mutation of the GTP-cyclohydrase I (GCH1) gene.
Topics: Biopterins; Chromosome Aberrations; DNA Mutational Analysis; Dopamine Agents; Dystonic Disorders; Female; Genes, Dominant; GTP Cyclohydrolase; Humans; Levodopa; Middle Aged; Mutation; Neopterin; Neurologic Examination; Pedigree; Polymerase Chain Reaction | 2006 |
Frequency of GCH1 deletions in Dopa-responsive dystonia.
Topics: Adolescent; Adult; Antiparkinson Agents; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Cohort Studies; DNA Mutational Analysis; Dystonic Disorders; Female; Gene Frequency; Genes, Dominant; GTP Cyclohydrolase; Humans; Infant; Levodopa; Male; Microsatellite Repeats; Penetrance; Point Mutation; Sequence Analysis, Protein | 2008 |
Striatal histone modifications in models of levodopa-induced dyskinesia.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylation; Animals; Chromatin; Chromosome Aberrations; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Extracellular Signal-Regulated MAP Kinases; Female; Histones; Levodopa; Macaca mulatta; Male; Methylation; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Phosphorylation; Protein Processing, Post-Translational; Species Specificity | 2008 |
IgA deficiency associated with growth hormone deficiency in a boy with short arm deletion of chromosome 18 (46,XY,18p-).
Topics: Arginine; Child; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 18; Developmental Disabilities; Dwarfism, Pituitary; Growth Hormone; Humans; IgA Deficiency; Insulin; Intellectual Disability; Levodopa; Male; Pituitary Function Tests; Propranolol; Sequence Deletion | 1994 |
A family with hereditary juvenile dystonia-parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Chromosome Aberrations; Chromosome Disorders; Dystonia; Female; Follow-Up Studies; Genes, Dominant; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pedigree; Torticollis | 1995 |
A clue to the pathogenesis of dopa-responsive dystonia.
Topics: Biopterins; Chromosome Aberrations; Chromosome Disorders; Corpus Striatum; Dopamine; Dystonia; Humans; Levodopa; Neopterin; Tyrosine 3-Monooxygenase | 1995 |
Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome.
Topics: Adolescent; Adult; Brain Diseases; Carbidopa; Child; Chromosome Aberrations; Chromosome Disorders; Consanguinity; Dementia; Electromyography; Extrapyramidal Tracts; Female; Globus Pallidus; Humans; Immobilization; Levodopa; Magnetic Resonance Imaging; Male; Pedigree; Syndrome | 1994 |
Dopa responsive dystonia with Turner's syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene.
Topics: Adult; Antiparkinson Agents; Brain; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 14; Cognition Disorders; Dystonia; Exons; Female; GTP Cyclohydrolase; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Pedigree; Point Mutation; Turner Syndrome | 1998 |
Levodopa responsive parkinsonism in an adult with Huntington's disease.
Topics: Adult; Antiparkinson Agents; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 4; Humans; Huntington Disease; Levodopa; Male; Pedigree | 1998 |
Reduced spontaneous growth hormone secretion in patients with Turner's syndrome.
Topics: Adolescent; Age Determination by Skeleton; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Dopamine Agents; Down Syndrome; Electronic Data Processing; Female; Growth Disorders; Human Growth Hormone; Humans; Karyotyping; Levodopa; Male; Radioimmunoassay; Turner Syndrome; X Chromosome | 1999 |
PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.
Topics: Adult; alpha-Synuclein; Antiparkinson Agents; Brain Mapping; Caudate Nucleus; Chromosome Aberrations; Chromosome Disorders; Female; Gene Expression; Genes, Dominant; Greece; Humans; Levodopa; Male; Middle Aged; Mutation; Nerve Tissue Proteins; Parkinson Disease; Pedigree; Phosphoproteins; Putamen; Receptors, Dopamine; Synucleins; Tomography, Emission-Computed; United States | 1999 |
Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness.
Topics: Carbidopa; Child; Chromosome Aberrations; Chromosome Disorders; Circadian Rhythm; Drug Combinations; Dystonic Disorders; Gait; Genes, Dominant; GTP Cyclohydrolase; Humans; Levodopa; Male; Muscle Hypotonia; Muscle Weakness; Neurologic Examination; Point Mutation; Treatment Outcome | 2001 |
X-linked dystonia ("Lubag") presenting predominantly with parkinsonism: a more benign phenotype?
Topics: Adult; Antiparkinson Agents; Chromosome Aberrations; Dystonic Disorders; Humans; Levodopa; Male; Parkinsonian Disorders; Phenotype; X Chromosome | 2002 |